Article Versions Notes

Davarci G, Wängler C, Eberhardt K, Tulessin M, Geppert C, Schirrmacher R, Fricker G, Mogler C, Pretze M, Wängler B. Preclinical Evaluation of Stable Integrin α_vβ₃-Specific [¹⁹⁸Au]Gold Nanoparticles for Tumor Therapy. Pharmaceuticals. 2025; 18(11):1670. https://doi.org/10.3390/ph18111670

Davarci, Güllü, Carmen Wängler, Klaus Eberhardt, Margaret Tulessin, Christopher Geppert, Ralf Schirrmacher, Gert Fricker, Carolin Mogler, Marc Pretze, and Björn Wängler. 2025. "Preclinical Evaluation of Stable Integrin α_vβ₃-Specific [¹⁹⁸Au]Gold Nanoparticles for Tumor Therapy" Pharmaceuticals 18, no. 11: 1670. https://doi.org/10.3390/ph18111670

Davarci, G., Wängler, C., Eberhardt, K., Tulessin, M., Geppert, C., Schirrmacher, R., Fricker, G., Mogler, C., Pretze, M., & Wängler, B. (2025). Preclinical Evaluation of Stable Integrin α_vβ₃-Specific [¹⁹⁸Au]Gold Nanoparticles for Tumor Therapy. Pharmaceuticals, 18(11), 1670. https://doi.org/10.3390/ph18111670